Skip to main content
HR 4832 107th Congress House Health Clinical trials Congress Congressional reporting requirements Cost effectiveness Drugs Electronic government information Finance and Financial Sector Government Operations and Politics Government publicity Internet Medicaid Medicare Pharmaceutical research Science, Technology, Communications Social Welfare

Prescription Drug Comparative Effectiveness Act of 2002

Introduced: May 23, 2002 See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 107th Congress ended
It never became law before the 107th Congress (2001–2002) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 3, 2002
Referred to the Subcommittee on Health.
May 23, 2002
Referred to the House Committee on Energy and Commerce.
May 23, 2002
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service
Prescription Drug Comparative Effectiveness Act of 2002 - Directs the Director of the Agency for Healthcare Research and Quality to study, analyze, and report to Congress on valid scientific evidence regarding the comparative effectiveness and cost-effectiveness, relative to other drugs and treatments, of prescription drugs that account for high levels of expenditures or use by individuals entitled to benefits under titles XVIII (Medicare) or XIX (Medicaid) of the Social Security Act.
What's happening now June 3, 2002

Referred to the Subcommittee on Health.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Cosponsors 3
All 3 Democratic 3
D
Norton, Eleanor Holmes
District of Columbia · Jun 20, 2002
 D
DeLauro, Rosa L.
Connecticut · May 23, 2002
 D
Kaptur, Marcy
Ohio · May 23, 2002
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 4832: Prescription Drug Comparative Effectiveness Act of 2002. 107th Congress. Open America. https://openamerica.io/bill/107-HR-4832/
MLA
"H.R. 4832: Prescription Drug Comparative Effectiveness Act of 2002." 107th Congress, 2026, Open America, https://openamerica.io/bill/107-HR-4832/.
Bluebook (legal)
H.R. 4832, 107th Cong. (2026), https://openamerica.io/bill/107-HR-4832/.
Markdown link
[H.R. 4832: Prescription Drug Comparative Effectiveness Act of 2002](https://openamerica.io/bill/107-HR-4832/)
Report a problem